Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents
Carmen Garrido-Navas,
Diego de Miguel-Perez,
Jose Exposito-Hernandez,
Clara Bayarri,
Victor Amezcua,
Alba Ortigosa,
Javier Valdivia,
Rosa Guerrero,
Jose Luis Garcia Puche,
Jose Antonio Lorente,
Maria José Serrano
Affiliations
Carmen Garrido-Navas
GENYO, Centre for Genomics and Oncological Research (Pfizer / University of Granada / Andalusian Regional Government), PTS Granada Av. de la Ilustración, 114, 18016, Granada, Spain
Diego de Miguel-Perez
GENYO, Centre for Genomics and Oncological Research (Pfizer / University of Granada / Andalusian Regional Government), PTS Granada Av. de la Ilustración, 114, 18016, Granada, Spain
Jose Exposito-Hernandez
Integral Oncology Division, Virgen de las Nieves University Hospital, Av. Dr. Olóriz 16, 18012, Granada, Spain
Clara Bayarri
GENYO, Centre for Genomics and Oncological Research (Pfizer / University of Granada / Andalusian Regional Government), PTS Granada Av. de la Ilustración, 114, 18016, Granada, Spain
Victor Amezcua
Integral Oncology Division, Virgen de las Nieves University Hospital, Av. Dr. Olóriz 16, 18012, Granada, Spain
Alba Ortigosa
GENYO, Centre for Genomics and Oncological Research (Pfizer / University of Granada / Andalusian Regional Government), PTS Granada Av. de la Ilustración, 114, 18016, Granada, Spain
Javier Valdivia
Integral Oncology Division, Virgen de las Nieves University Hospital, Av. Dr. Olóriz 16, 18012, Granada, Spain
Rosa Guerrero
Integral Oncology Division, Virgen de las Nieves University Hospital, Av. Dr. Olóriz 16, 18012, Granada, Spain
Jose Luis Garcia Puche
GENYO, Centre for Genomics and Oncological Research (Pfizer / University of Granada / Andalusian Regional Government), PTS Granada Av. de la Ilustración, 114, 18016, Granada, Spain
Jose Antonio Lorente
GENYO, Centre for Genomics and Oncological Research (Pfizer / University of Granada / Andalusian Regional Government), PTS Granada Av. de la Ilustración, 114, 18016, Granada, Spain
Maria José Serrano
GENYO, Centre for Genomics and Oncological Research (Pfizer / University of Granada / Andalusian Regional Government), PTS Granada Av. de la Ilustración, 114, 18016, Granada, Spain
Metastasis is the leading cause of cancer-related deaths and despite measurable progress in the field, underlying mechanisms are still not fully understood. Circulating tumor cells (CTCs) disseminate within the bloodstream, where most of them die due to the attack of the immune system. On the other hand, recent evidence shows active interactions between CTCs and platelets, myeloid cells, macrophages, neutrophils, and other hematopoietic cells that secrete immunosuppressive cytokines, which aid CTCs to evade the immune system and enable metastasis. Platelets, for instance, regulate inflammation, recruit neutrophils, and cause fibrin clots, which may protect CTCs from the attack of Natural Killer cells or macrophages and facilitate extravasation. Recently, a correlation between the commensal microbiota and the inflammatory/immune tone of the organism has been stablished. Thus, the microbiota may affect the development of cancer-promoting conditions. Furthermore, CTCs may suffer phenotypic changes, as those caused by the epithelial−mesenchymal transition, that also contribute to the immune escape and resistance to immunotherapy. In this review, we discuss the findings regarding the collaborative biological events among CTCs, immune cells, and microbiome associated to immune escape and metastatic progression.